Key result
Elevated inflammatory biomarkers including hs-CRP are linked to cognitive decline in AF patients.
Why the study?
Emerging evidence suggests a link between AF and cognitive decline, but the underlying mechanisms and the role of inflammation remain incompletely understood.
Are inflammatory biomarkers associated with cognitive decline in patients with atrial fibrillation?
Systematic Review (n=1,299)
Are inflammatory biomarkers associated with cognitive decline in patients with atrial fibrillation?
Inflammatory biomarkers, particularly hs-CRP, appear to be associated with cognitive decline in patients with atrial fibrillation, suggesting inflammation may be a mediating pathophysiological pathway.
May flag cognitive risk via hs-CRP in AF; leaves open whether targeting inflammation alters outcomes.
Atrial fibrillation (AF) and cognitive decline represent significant health challenges with increasing prevalence and significant socioeconomic implications. Emerging evidence suggests a potential link between AF and cognitive decline, including dementia and Alzheimer's disease, although the underlying mechanisms remain incompletely understood. Inflammation has emerged as a key mediator in cardiovascular and neurological diseases, encouraging an investigation into its role in the atrial fibrillation-cognition association. A systematic search of PubMed, Web of Science, and PsycInfo was conducted to identify relevant studies investigating possible inflammatory mechanisms bridging AF and cognitive decline. Studies were assessed for quality and relevance, and data were synthesized using a narrative approach. Five papers were included, with only two longitudinal studies. Inflammatory biomarkers emerged as significant factors associated with both AF and cognitive decline. Three studies revealed a correlation between high-sensitivity CRP (HS-CRP) levels and cognitive decline in patients with AF, AF patients with cerebral infarction, and elderly individuals with AF. However, conflicting results were observed, as one study did not identify any associations between cognitive decline and HS-CRP levels. The scientific literature on this topic is scarce, and the results of existing studies often lack consistency in their findings, highlighting the need for further research to better understand and prevent this significant health burden in patients with AF. So, the results of this study are expected to inform future research directions and cognitive decline risk stratification, guiding the development of targeted interventions aimed at preserving cognitive function and improving outcomes in patients with AF.
No takes yet. Share an insight, caveat, or question.
Machado et al. (2025) conducted a systematic review in Atrial fibrillation and cognitive decline (n=1,299). Inflammatory biomarkers (e.g., HS-CRP) was evaluated on Association between inflammatory markers and cognitive decline. In a systematic review of five studies, elevated inflammatory biomarkers, particularly high-sensitivity C-reactive protein, were associated with cognitive decline in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Atrial fibrillationMore from Neurological Sciences